Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

Sangamo Therapeutics, Inc

Biological Products, (No Diagnostic Substances) · Richmond, CA, United States

  1. PrincipalsNathalie Dubois-StringfellowSVP-CHIEF DEVELOPMENT OFFICERSandy MacraePRESIDENT, CEO AND DIRECTORScott B. WilloughbySVP, CHIEF LEGAL OFFICER, SECYand 3 more
  2. CompanySangamo Therapeutics, IncRichmond, CA, United States
  3. Phone line+1 (510) 970-6000General business
Request a quote

Sangamo Therapeutics, Inc is an SEC-registered OTC-listed company (ticker SGMOQ) classified under SIC 2836: Biological Products, (No Diagnostic Substances).

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2836 — Biological Products, (No Diagnostic Substances) — SEC EDGAR company submissions

People 6

Chief executive

Sandy MacraePRESIDENT, CEO AND DIRECTOR

Technology & engineering

Gregory D DavisHead of Research & Technology

Legal

Scott B. WilloughbySVP, CHIEF LEGAL OFFICER, SECY
Everyone else on file (3)
Nathalie Dubois-StringfellowSVP-CHIEF DEVELOPMENT OFFICER
Nikunj JainPrincipal Accounting Officer
Prathyusha DuraibabuPRINCIPAL FINANCIAL OFFICER

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Nathalie Dubois-Stringfellow — SVP-CHIEF DEVELOPMENT OFFICER

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. Sandy Macrae — PRESIDENT, CEO AND DIRECTOR

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. Scott B. Willoughby — SVP, CHIEF LEGAL OFFICER, SECY

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  5. Gregory D Davis — Head of Research & Technology

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers